Related Experiment Videos
[Primary transitional carcinoma of the prostatic ductus]
J A Queipo Zaragozá1, A Budía Alba, M Pérez Ebrí
1Servicio de Urología, Hospital Universitario La Fe, Valencia.
Actas Urologicas Espanolas
|August 31, 2000
Summary
Primary prostate transitional cell carcinoma is a rare cancer. This aggressive tumor shows poor prognosis and hormone resistance, with radical surgery offering the best chance for increased life expectancy.
Area of Science:
- Uro-oncology
- Pathology
- Medical Oncology
Context:
- Primary prostate transitional cell carcinoma is an exceptionally rare malignancy.
- It originates from the transitional epithelial cells within the intraprostate periurethral ductus.
- This study analyzed 17 cases of prostate transitional cell carcinoma among 829 prostate carcinoma diagnoses.
Purpose:
- To retrospectively investigate the clinical behavior and outcomes of primary prostate transitional cell carcinoma.
- To compare its characteristics with acinar prostate adenocarcinoma.
- To identify factors influencing diagnosis and prognosis.
Summary:
- The study evaluated clinical presentation, digital rectal exam (DRE), prostate-specific antigen (PSA), metastatic spread, and obstructive uropathy.
- Radiotherapy was the predominant treatment modality.
- Mean survival was 26.6 months, with 11 deaths recorded.
- Prostate transitional cell carcinoma exhibits aggressive, hormone-resistant behavior with a poor prognosis compared to acinar forms.
Impact:
- Findings highlight the aggressive nature and poor prognosis of prostate transitional cell carcinoma.
- Early diagnosis and radical surgery are crucial for improving patient survival.
- This research contributes to understanding a rare but aggressive prostate cancer variant.